how-to
How to Navigate CE/MDR Frameworks for Medical Device Market Access
Last Updated: October 30, 2026
Quick Summary
Navigating the CE MDR framework means defining your device's intended purpose, classifying it under Annex VIII, selecting the conformity assessment route, compiling technical documentation and clinical evaluation, then signing the EU Declaration of Conformity, registering in EUDAMED and affixing CE marking. Class I devices can usually self-declare, while higher classes need a notified body.
- Annex VIII sorts devices into four risk classes: Class I, Class IIa, Class IIb and Class III.
- Class I sterile, measuring or reusable surgical devices still need notified body involvement.
- If two classification rules could apply, the higher class wins and the tie-break must be documented.
- Legacy devices must have lodged a notified body application with confirmation by May 26, 2024.
- The extended transition ends December 31, 2028 for Class IIa and IIb non-implantable devices.
Table of Contents
- Understanding the EU MDR CE Marking Process: A Step-by-Step Guide
- Step 1: Define Intended Purpose and Confirm Device Status
- Step 2: Classify the Device Under Annex VIII
- Step 3: Select the Conformity Assessment Route and Engage a Notified Body
- Step 4: Compile Technical Documentation and Conduct Clinical Evaluation
- Step 5: Issue the EU Declaration of Conformity, Register in EUDAMED, and Affix CE Marking
- EU MDR Medical Device Classification: Risk Classes and Their Impact on Conformity Routes
- EU MDR Technical Documentation: Annex Requirements and Common Pitfalls
- EU MDR vs FDA: Key Differences in Regulatory Strategy
- Common Application Errors and Audit Findings in CE/MDR Submissions
- Transition Deadlines and Legacy Device Eligibility Under the EU MDR
- Planning Your CE/MDR Compliance Strategy with E & E Medicals and Consulting
- Frequently Asked Questions
Understanding the EU MDR CE Marking Process: A Step-by-Step Guide
Getting a medical device onto the EU market means proving it meets the EU Medical Device Regulation, usually called MDR. This guide walks you through the full CE MDR framework, from defining your device to affixing the mark.
Below, we break the CE/MDR frameworks into five clear stages. Each stage builds on the last, so skipping ahead creates problems later. Start with the definition, then classify, then choose your route.
Step 1: Define Intended Purpose and Confirm Device Status
The intended purpose is the foundation of everything. It states what your device does, who uses it, and on which patients. Every later decision depends on this statement.
Ask two questions first:
- Is the product a medical device under the MDR at all?
- Does a separate rule, such as a drug or cosmetic rule, take priority?
Write the intended purpose in plain, precise language. Vague wording invites scrutiny from a notified body later.
Step 2: Classify the Device Under Annex VIII
Device classification uses Annex VIII of the MDR. It sorts devices into four risk classes: Class I, Class IIa, Class IIb, and Class III.
The rules in Annex VIII depend on how long a device touches the body, how invasive it is, and whether it delivers medicine. A common mistake is guessing the class. Work through each relevant rule in writing and keep your reasoning on file.
Step 3: Select the Conformity Assessment Route and Engage a Notified Body
Your risk class decides your conformity route. Class I devices, in most cases, can use self-declaration. Higher classes need a notified body to assess the device.
A notified body is an independent group the EU approves to check compliance. Choosing the right one matters. Check its scope covers your device type before you sign a contract.
Here is a simple decision guide:
| Device Class | Typical Route | Notified Body Needed? |
|---|---|---|
| Class I (non-sterile, no measuring) | Self-declaration | No |
| Class I (sterile or measuring) | QMS plus technical review | Yes |
| Class IIa | Annex IX, often with product sampling | Yes |
| Class IIb | Annex IX full assessment | Yes |
| Class III | Annex IX, with clinical review | Yes |
Step 4: Compile Technical Documentation and Conduct Clinical Evaluation
Technical documentation is the evidence file that proves your device meets the general safety and performance requirements. It includes design data, risk management, labeling, and instructions for use.
Clinical evaluation is the ongoing review of clinical evidence for your device. For more detail on what that report must contain, see our breakdown of EU MDR clinical evaluation report requirements.
Watch out: a thin or copy-pasted CER is one of the most common reasons a notified body sends an application back.
Step 5: Issue the EU Declaration of Conformity, Register in EUDAMED, and Affix CE Marking
Once your assessment passes, you sign the EU Declaration of Conformity. This is your formal statement that the device meets the MDR.
Next, register the device in EUDAMED, the EU's device database. Then assign a UDI, the unique device identifier. Finally, affix the CE marking to the device and its packaging.
The CE mark is not the end. Post-market surveillance and vigilance duties continue for the life of the device.
EU MDR Medical Device Classification: Risk Classes and Their Impact on Conformity Routes
Classification is the single decision that drives your conformity route, your notified body costs, your timeline, and how much clinical evidence a reviewer will demand. The MDR sets four risk classes under Annex VIII, and each one changes what you must do, not just how much paperwork you file.
- Class I: lowest risk. Most non-sterile, non-measuring devices can self-declare. Sterile Class I, measuring Class I, and reusable surgical instruments still need notified body involvement.
- Class IIa: moderate risk. Notified body review, typically Annex IX with product sampling under Annex IX Section 3.
- Class IIb: higher risk. Full Annex IX assessment, including review of the technical documentation for each device.
What actually moves a device up a class
Annex VIII is a set of rules, not a vibe check. The drivers that most often push a device into a higher class are:
- Duration of contact: transient (under 60 minutes), short-term (60 minutes to 30 days), and long-term (over 30 days) each trigger different rules.
- Invasiveness: non-invasive, body-orifice invasive, surgically invasive, and implantable devices are treated very differently.
- Active vs. non-active: active devices that administer or exchange energy or medicinal substances often land in a higher class.
A practical decision tree for selecting your route
Use this sequence to move from device description to conformity route. Work it in writing and keep the reasoning in your technical file, auditors ask for it.
- Is the product a medical device under Article 2? If no, the MDR does not apply and you stop here.
- Does a special rule take priority? Medicinal products, cosmetics, and certain combination products may fall under other regimes.
- Apply Annex VIII rules in order. Start with the rule that matches your device's invasiveness and duration, then check whether any special rule escalates it.
- Confirm the class in writing. Record which rule applied and why. This is the most common audit finding.
- Map class to route:
- Class I (non-sterile, non-measuring, non-reusable-surgical): self-declaration, no notified body.
- Class I (sterile, measuring, or reusable surgical): notified body for the QMS and technical documentation aspects.
- Class IIa: Annex IX, often with sampling of technical documentation.
- Class IIb: Annex IX full assessment.
- Class III: Annex IX full assessment plus clinical evaluation scrutiny.
Why getting classification wrong is expensive
A misclassified device does not just fail review; it invalidates the route you built around it. A device wrongly placed in Class I will be rejected at the self-declaration stage, and a device wrongly placed in Class IIa may need a new notified body contract and a fresh technical file review.
For the full rule text, see Annex VIII of Regulation (EU) 2017/745 on the European Commission MDR page.
EU MDR Technical Documentation: Annex Requirements and Common Pitfalls
Technical documentation is the core evidence package under the MDR. It must show compliance with the general safety and performance requirements, and it must stay current.
Key parts include:
- Device description and intended purpose
- Design and manufacturing information
- Risk management per ISO 14971
Risk management is where many files fall short.
Watch out: leaving the risk file as a last-minute add-on creates gaps a reviewer will spot fast.
EU MDR vs FDA: Key Differences in Regulatory Strategy
The EU and US pathways reward different thinking. Under the MDR, you build a single technical file and get a notified body to assess it. Under the FDA, you submit a specific application, such as a 510(k) or De Novo, and the agency reviews it.
- Approval model: MDR relies on notified bodies; FDA reviews directly.
- Ongoing duty: MDR puts heavy weight on post-market surveillance.
- Evidence: Both demand clinical evidence, but the format differs.
If you market in both regions, plan the two strategies together. See our FDA requirements overview to contrast US obligations with MDR duties.
Common Application Errors and Audit Findings in CE/MDR Submissions

- Intended purpose written too broadly
- Classification reasoning not documented
- Clinical evaluation report lacking real evidence
A common mistake is treating the technical file as a one-time task. Auditors check that it is current and matches the device you actually ship.
Transition Deadlines and Legacy Device Eligibility Under the EU MDR
Legacy devices are those placed on the market under the older Medical Devices Directive (MDD) or Active Implantable Medical Devices Directive (AIMDD) and kept available under the MDR's transition provisions. The transition periods exist so manufacturers can update files without pulling safe devices off the market, but eligibility is conditional, and the conditions are where most manufacturers get caught out.
The dated timeline manufacturers actually plan against
The MDR entered into force in May 2017 and applied from May 26, 2021. Regulation (EU) 2023/607 then amended the transition provisions and removed the original "sell-off" deadline for devices already placed on the market. The practical dates to plan against are:
- May 26, 2021: MDR applies. Legacy devices may continue to be placed on the market only if the transition conditions are met.
- May 26, 2024: original transition end for most legacy devices under the pre-amendment rules.
- May 26, 2026: extended transition end for Class III custom-made implantable devices and certain Class III devices, subject to conditions.
Dates are set in the regulation and have been amended before; confirm the current text on the European Commission MDR page before you lock a launch plan.
Eligibility conditions for legacy devices
A legacy device does not automatically benefit from the extended timeline. Under the amended Article 120, all of the following must hold:
- The device continues to comply with the directive it was certified under.
- The device's design and intended purpose have not undergone significant changes.
- The device does not present an unacceptable risk to health or safety.
What to do now, regardless of your class
- Audit your certificates. Confirm the expiry date and scope of every MDD/AIMDD certificate you rely on.
- Lodge the MDR application early. The notified body confirmation is a hard gate, not a formality.
- Sign the written agreement. Track the September 26, 2024 milestone if you have not already.
Planning Your CE/MDR Compliance Strategy with E & E Medicals and Consulting
A strong CE/MDR strategy connects every stage, from intended purpose to post-market surveillance. That lifecycle view is what separates a smooth submission from a costly rework.
Device teams can work with E & E Medicals and Consulting on FDA regulatory expertise, quality management, and ISO compliance consulting. To discuss your route and timeline, contact the team through the website.
Frequently Asked Questions
What is the difference between ISO 13485 and EU MDR?
ISO 13485 is a voluntary quality management system standard, while EU MDR is a mandatory regulation for medical devices in the EU. ISO 13485 provides a framework for quality processes, but EU MDR sets legal requirements for safety, performance, clinical evaluation, and CE marking. Compliance with ISO 13485 supports MDR obligations but does not replace them. Manufacturers must integrate both to demonstrate conformity.
What are the main steps to obtain CE marking under the EU MDR?
The CE MDR CE marking process involves five core steps: define the device's intended purpose and confirm it falls under MDR; classify it under Annex VIII; select the appropriate conformity assessment route (self-certification for Class I, notified body for higher classes); compile technical documentation and conduct clinical evaluation; and issue the EU Declaration of Conformity, register in EUDAMED, and affix the CE mark. Each step requires careful documentation and risk management.
How does medical device classification affect the EU MDR conformity assessment?
EU MDR medical device classification assigns devices to Class I, IIa, IIb, or III based on risk. Class I devices (non-sterile, non-measuring) can often use self-certification, while higher classes require notified body involvement. Classification determines the conformity assessment route, the depth of technical documentation, and clinical evidence requirements. Misclassification is a common error that can delay market access.
When does a medical device manufacturer need a notified body under the EU MDR?
A notified body is required for all Class IIa, IIb, and III devices, and for Class I devices that are sterile, have a measuring function, or are reusable surgical instruments. The notified body audits the quality management system and reviews technical documentation. Manufacturers should engage a notified body early, as waiting lists can be long and the assessment process is thorough.
The MDR rewards preparation and punishes guesswork. If your team needs a clear path from classification to CE marking, E & E Medicals and Consulting can help. We bring FDA regulatory expertise, ISO compliance consulting, and quality management support to every engagement. Get started with E & E Medicals and Consulting and move your device toward EU market access with confidence.